Published in J Neurol on March 01, 2003
Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage (2010) 1.71
The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging (2011) 1.30
Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry (2003) 1.15
Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J Neurol Neurosurg Psychiatry (2006) 0.97
Deep gray matter and fatigue in MS: a T1 relaxation time study. J Neurol (2006) 0.92
Optimized T1-MPRAGE sequence for better visualization of spinal cord multiple sclerosis lesions at 3T. AJNR Am J Neuroradiol (2013) 0.89
Spinal cord normalization in multiple sclerosis. J Neuroimaging (2014) 0.88
Age, gender and normalization covariates for spinal cord gray matter and total cross-sectional areas at cervical and thoracic levels: A 2D phase sensitive inversion recovery imaging study. PLoS One (2015) 0.83
Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T. Neuroradiology (2012) 0.79
Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data. AJNR Am J Neuroradiol (2009) 0.77
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol (2008) 3.13
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol (2008) 2.58
Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation (2003) 2.43
Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus. Nat Genet (2006) 2.08
Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg (2008) 1.89
Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med (2002) 1.76
'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment. J Neurol Sci (2005) 1.65
Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation (2003) 1.58
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial. Lancet Neurol (2010) 1.56
TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. J Immunol (2011) 1.47
A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol (2009) 1.46
Volitional reduction of anterior cingulate cortex activity produces decreased cue craving in smoking cessation: a preliminary real-time fMRI study. Addict Biol (2012) 1.36
Extrahippocampal gray matter loss and hippocampal deafferentation in patients with temporal lobe epilepsy. Epilepsia (2010) 1.33
Fatigue in multiple sclerosis - a brief review. J Neurol Sci (2012) 1.29
Impaired speech repetition and left parietal lobe damage. J Neurosci (2010) 1.24
Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin (2013) 1.23
Measurement of spinal cord atrophy in multiple sclerosis. J Neuroimaging (2004) 1.22
In vivo mapping of the human locus coeruleus. Neuroimage (2009) 1.21
Mapping anterior temporal lobe language areas with fMRI: a multicenter normative study. Neuroimage (2010) 1.21
Parietal updating of limb posture: an event-related fMRI study. Neuropsychologia (2006) 1.18
A regularized two-tensor model fit to low angular resolution diffusion images using basis directions. J Magn Reson Imaging (2008) 1.15
T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Mov Disord (2011) 1.14
Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain (2013) 1.14
Cannabinoids and the immune system: an overview. Immunobiology (2010) 1.13
MR tagging of human lungs using hyperpolarized 3He gas. J Magn Reson Imaging (2003) 1.13
Intermittent "real-time" fMRI feedback is superior to continuous presentation for a motor imagery task: a pilot study. J Neuroimaging (2010) 1.12
Compensatory neural reorganization in Tourette syndrome. Curr Biol (2011) 1.11
Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging (2011) 1.07
Measuring the hemodynamic response in chronic hypoperfusion. Neurocase (2006) 1.05
3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J Magn Reson Imaging (2010) 1.03
fMRI analysis of active, passive and electrically stimulated ankle dorsiflexion. Neuroimage (2008) 1.03
Covert orienting of attention and overt eye movements activate identical brain regions. Brain Res (2008) 1.03
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun (2007) 1.00
Motor threshold in transcranial magnetic stimulation: the impact of white matter fiber orientation and skull-to-cortex distance. Hum Brain Mapp (2009) 1.00
Measurement of cervical spinal cord cross-sectional area by MRI using edge detection and partial volume correction. J Magn Reson Imaging (2005) 0.99
Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome. Mult Scler (2012) 0.98
Brain tractography using Q-ball imaging and graph theory: Improved connectivities through fibre crossings via a model-based approach. Neuroimage (2009) 0.98
Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. JAMA Neurol (2013) 0.98
Upper cervical spinal cord cross-sectional area in relapsing remitting multiple sclerosis: application of a new technique for measuring cross-sectional area on magnetic resonance images. J Magn Reson Imaging (2007) 0.97
Spatial attention evokes similar activation patterns for visual and auditory stimuli. J Cogn Neurosci (2010) 0.97
Neurofilament ELISA validation. J Immunol Methods (2009) 0.96
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations. J Neurol (2013) 0.96
Role of the human supplementary eye field in the control of saccadic eye movements. Neuropsychologia (2006) 0.96
Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed (2015) 0.96
Plaque hemorrhage is a marker of thromboembolic activity in patients with symptomatic carotid disease. Radiology (2010) 0.96
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. J Neurol Neurosurg Psychiatry (2012) 0.95
Cerebral perfusion in chronic stroke: implications for lesion-symptom mapping and functional MRI. Behav Neurol (2011) 0.95
Advances in the treatment of relapsing-remitting multiple sclerosis. Biomed J (2014) 0.94
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. Schizophr Res (2007) 0.94
White matter T(1) relaxation time histograms and cerebral atrophy in multiple sclerosis. J Neurol Sci (2002) 0.93
Brain white matter hyperintensities are associated with carotid intraplaque hemorrhage. Radiology (2008) 0.93
Interaction between cytokines, cannabinoids and the nervous system. Immunobiology (2010) 0.93
Focal multiple sclerosis lesions abound in 'normal appearing white matter'. Mult Scler (2011) 0.92
Brain damage and cortical compensation in foreign accent syndrome. Neurocase (2005) 0.91
Improved artifact correction for combined electroencephalography/functional MRI by means of synchronization and use of vectorcardiogram recordings. J Magn Reson Imaging (2008) 0.91
Mitochondrial changes in leukocytes of patients with optic neuritis. Mol Vis (2007) 0.90
Evaluation of an adjustment group for people with multiple sclerosis and low mood: a randomized controlled trial. Mult Scler (2011) 0.89
Diffusion-weighted magnetic resonance imaging of normal and degenerative lumbar intervertebral discs: a new method to potentially quantify the physiologic effect of physical therapy intervention. J Orthop Sports Phys Ther (2007) 0.89
Oscillopsia without nystagmus caused by head titubation in a patient with multiple sclerosis. J Neuroophthalmol (2002) 0.89
Association of a deficit of arousal with fatigue in multiple sclerosis: effect of modafinil. Neuropharmacology (2012) 0.88
Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases. Inflamm Allergy Drug Targets (2009) 0.87
The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS). Inflamm Allergy Drug Targets (2010) 0.87
Structural white matter abnormalities in patients with idiopathic dystonia. Mov Disord (2007) 0.87
Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent. J Leukoc Biol (2006) 0.86
Cost-effectiveness of disease-modifying therapies in multiple sclerosis. Curr Neurol Neurosci Rep (2012) 0.86
Spinal cord imaging in multiple sclerosis. J Neuroimaging (2005) 0.86
Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis. Neuroimmunomodulation (2009) 0.86
Modulation of regulatory T cells in health and disease: role of toll-like receptors. Inflamm Allergy Drug Targets (2009) 0.86
Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis. Arch Neurol (2008) 0.86
Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells. J Cell Mol Med (2007) 0.86
Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled FMRI study. Front Psychiatry (2010) 0.86
A quantitative analysis of the benefits of cardiac gating in practical diffusion tensor imaging of the brain. Magn Reson Med (2010) 0.85
Discrepant effects of human interferon-gamma on clinical and immunological disease parameters in a novel marmoset model for multiple sclerosis. J Neuroimmune Pharmacol (2011) 0.85
Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol (2013) 0.84
Replication of Functional MRI Detection of Deception. Open Forensic Sci J (2009) 0.84
How common is brain atrophy in patients with medial temporal lobe epilepsy? Epilepsia (2010) 0.84
Re-evaluation of iliac compression syndrome using magnetic resonance imaging in patients with acute deep venous thromboses. J Vasc Surg (2004) 0.84
Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats. J Neurol Sci (2007) 0.83
Disrupted thalamic prefrontal pathways in patients with idiopathic dystonia. Parkinsonism Relat Disord (2008) 0.83
Deep venous thrombosis: diagnosis by using venous enhanced subtracted peak arterial MR venography versus conventional venography. Radiology (2003) 0.83
Are current disease-modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis? J Neurochem (2010) 0.82
A presenilin 1 mutation (Arg278Ser) associated with early onset Alzheimer's disease and spastic paraparesis. J Neurol Sci (2007) 0.81
Age-related relative volume preservation of the dominant hand cortical region. Brain Res (2009) 0.81
Cannabinoids and experimental models of multiple sclerosis. Immunobiology (2009) 0.81
Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix. PLoS One (2013) 0.81
Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis. J Neuroimmune Pharmacol (2015) 0.81
A comparative audit of anticardiolipin antibodies in oligoclonal band negative and positive multiple sclerosis. Mult Scler (2005) 0.81
Multiple sclerosis, lymphoma and nasopharyngeal carcinoma: the central role of Epstein-Barr virus? Eur Neurol (2009) 0.81
Skeletal muscle myosin is the autoantigen for experimental autoimmune myositis. Exp Mol Pathol (2003) 0.81
Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis. Am J Ophthalmol (2002) 0.80
What role does tobacco smoking play in multiple sclerosis disability and mortality? A review of the evidence. Neurodegener Dis Manag (2015) 0.80
T1 relaxation time mapping of white matter tracts in multiple sclerosis defined by diffusion tensor imaging. J Neurol (2002) 0.79